M. D. Anderson Researchers Demonstrate Power Of MiRviewTM Mets To Identify...
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that results of a joint study with researchers at the show that Rosetta...
View ArticleCuris Announces Presentation Of Positive Vismodegib Pivotal Clinical Data In...
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being...
View ArticleScientists Fish For Answers About Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC), the most common type of liver cancer, is a leading cause of cancer-related deaths worldwide. Although there are several treatment options available, they are largely...
View ArticleFirst Genetic Sequencing Of Urothelial (Transitional) Carcinoma
In an article published online in Nature Genetics, a University of Colorado Cancer Center team in partnership with universities in China and Denmark reports the first genetic sequencing of urothelial...
View ArticleClik here to view.
Prognostic and Predictive Markers for Hepatocellular Cancer: Review of...
Prognostic and Predictive Markers for Hepatocellular Cancer: Review of markers assisting in treatment decision for Hepatocellular Carcinoma HCC is one of the most common malignancies worldwide. The...
View Article
